These effects at least in part involve the transport activity of MCT4, as inhibition of monocarboxylate transporters (Kong et al., 2016) or an MCT4 mutation abolishing transport (Li et al., 2021) attenuate cancer cell migration and invasion. Here, SLC16A3 is linked to cancer.